Dr. Joon-Yi Kang, MD

Dr. Kang practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Kang's NPI, 1518293695, was assigned on October 26, 2009. Dr. Kang holds Maryland license D80184.

Dr. Kang's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Kang's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Kang is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Kang to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kang practices. Vendor and product names are available with a free account.

Clinical neurophysiology is Dr. Kang's primary specialty in the NPI Registry, under taxonomy code 2084N0600X. Dr. Kang is licensed in Maryland.

CMS data shows 100 Medicare services from Dr. Kang across 3 procedure codes in 2024, for 82 Medicare patients. Medicare paid $11,269 for them.

CMS counts 82 Medicare patients who saw Dr. Kang in 2024. The largest group is under 65, with 33 patients. 67% of them have high cholesterol, and 65% have high blood pressure. 46% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kang's median patient age at 42, with 45% women.

In 2024, Dr. Kang wrote 556 Medicare Part D claims for 86 patients. 75% of them were for generic drugs. CMS names the drug for 480 of them, across 14 drugs with 11 or more claims each, at $250,389 in total drug cost. In 2023, CMS named 390 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kang for performance year 2024, reported as part of a group. CMS lists Dr. Kang as offering telehealth.

Dmand AI links 5 papers to Dr. Kang in 2025. 2025 was the busiest year, with 2. The most frequent topics are Electroencephalography, Epilepsy and Algorithms. Dr. Kang has published most often in Annu Int Conf IEEE Eng Med Biol Soc. Dr. Kang's most frequent co-authors are Niravkumar Barot, MD, Jorge Alvaro Gonzalez-Martinez, MD, PhD and Kareem Amir Zaghloul, MD.

Dmand AI links Dr. Kang to 1 clinical trial. Conditions studied include Epilepsy, Temporal Lobe and Epilepsies, Partial.

CMS Open Payments shows 18 general payments to Dr. Kang from 6 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 68% of the total. Eisai Inc. paid the most, $4,706.